Assessing the synergistic effect of the enhancer compound HT61 on Tobramycin activity in a murine model of pulmonary infection Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017
Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection Source: Eur Respir J 2007; 30: Suppl. 51, 493s Year: 2007
New synthetic compound cyclohexylmethoxy derivative inhibits asthmatic reaction in mouse model Source: Eur Respir J 2005; 26: Suppl. 49, 213s Year: 2005
The antimicrobial peptide CRAMP protects against emphysema Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012
Remission of allergy parameters by Fab and peptide mimotope vaccination in a murine model of asthma Source: Eur Respir J 2007; 30: Suppl. 51, 680s Year: 2007
Anti-inflammatory properties of synthetic and endogenous Rev-Erb-alpha agonists. Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020
Targeting neuropeptide receptors by substance-P analogues identifies a strategy to develop novel anti-cancer therapies Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008
Late Breaking Abstract - Anti-inflammatory activity of novel transtilbene sulfonamide analogues as potential novel therapeutic agents for inflammatory lung disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Efficacy of a novel PI3Kd inhibitor, DS-1515 in animal models of asthma Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018
The antimicrobial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands Source: Eur Respir J 2006; 28: Suppl. 50, 582s Year: 2006
Murine asthma induction: adjuvant and adjuvant-free models produce comparable phenotypes Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008
Effect of low-dose aspirin in a murine model of active tuberculosis Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017
Fast, efficient and realistic in vitro delivery of inhaled drugs to pulmonary cells: Application to the proteasome inhibitor bortezomib Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013
In vitro and in vivo pharmacological profile of RP6503, a novel dual PI3K Δ/gamma inhibitor, in pulmonary disease systemsSource: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013
In vitro pharmacological profile of SMP-028, a novel potent anti-inflammatory agentSource: Annual Congress 2010 - Models of airways disease Year: 2010
Screening and identification of functions site and inhibitory peptides of LBP Source: Eur Respir J 2005; 26: Suppl. 49, 406s Year: 2005
In vitro anti-inflammatory activity of the new glucocorticoid ciclesonide in human cellsSource: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001
Intratracheally administered recombinant adenovirus carrying a novel mutated IκBα gene abrogates pulmonary eosinophil inflammation in a murine asthma model Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006
Effect of a pan-JAK inhibitor pyridone 6 on airway responses in murine asthma model Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010